Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD - Related Studies

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

This study has been completed.

Study NCT00029614. Last updated on November 28, 2007. Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Substance Use Disorders

2	Additional conditions recognized in this trial
		Attention Deficit Disorder with Hyperactivity
		Disease
		Hyperkinesis
		Substance-Related Disorders

3	More general conditions related to this trial
		Attention Deficit and Disruptive Behavior Disorders
		Disorders of Environmental Origin
		Dyskinesias
		Mental Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

4	Interventions listed in this trial
		Atomoxetine

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs

6	Sponsors listed in this trial
		National Institute on Alcohol Abuse and Alcoholism (NIAAA)